Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_assertion description "[l-asparaginase-containing regimens such as SMILE (steroid, methotrexate, ifosfamide, l-asparaginase, and etoposide) are effective for ENKL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_assertion evidence source_evidence_literature NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_assertion SIO_000772 23768637 NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_assertion wasDerivedFrom befree-2016 NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_assertion wasGeneratedBy ECO_0000203 NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP1086064.RABmTJYMKzROZrWwuEjIxG6ndGpocRrWk-DOLoyV5lU4Q130_provenance.